Latest / Stock Movers / Vestas Jumps, Siemens Healthineers Dips, Novo Nordisk Up
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a lot now at some of the stocks
- 0:18Speaker 3: on the move today in Europe. I'm Leslie Burden alongside
- 0:20Speaker 3: Caroline Hepco and we're joined by Bloomberg reporter Chloe Melee Chloie.
- 0:24Speaker 3: Let's start with chairs investors, the daan aged wind developer.
- 0:27Speaker 3: Of course, they're surging after it announced this one hundred
- 0:30Speaker 3: and fifty million euro buyback.
- 0:32Speaker 1: And the resilient third quarter numbers were also quite well received,
- 0:36Speaker 1: so that is really reassuring investors that the turnaround at
- 0:39Speaker 1: that company is working and starting to pay off. Part
- 0:43Speaker 1: of the strategy was to raise prices and only supply
- 0:46Speaker 1: it turbines to the most profitable projects, and that seems
- 0:49Speaker 1: to have been working quite well for them. The industry
- 0:52Speaker 1: as a whole. That overall wind industry is still dealing
- 0:55Speaker 1: with quite a lot of setbacks, of course, with in
- 0:58Speaker 1: setbacks in the US in particular, and then supply chain
- 1:01Speaker 1: disruption more generally. The CEO did say that the current
- 1:04Speaker 1: environment was still creating unprecedented challenges. But that update from
- 1:09Speaker 1: Vestas and then another update that we got from AUSTED
- 1:12Speaker 1: today reassured investors generally that that kind of sector is
- 1:16Speaker 1: getting a little bit a little bit brighter. Al said,
- 1:20Speaker 1: shares also rose today after it kept its guidance, so
- 1:23Speaker 1: that helped to boost confidence that thinks can that the
- 1:27Speaker 1: worst is over for AUSTED after it had to raise
- 1:29Speaker 1: nine billion dollars if we remember, back in August and
- 1:32Speaker 1: September from shareholders. So the US market is still very
- 1:36Speaker 1: much going to have to be left to the side
- 1:38Speaker 1: for those wind companies because of how much Trump hates
- 1:41Speaker 1: wind turbines. But turning attention back to Europe might actually
- 1:45Speaker 1: work out quite well for them.
- 1:46Speaker 3: Okay, in terms of Trump policies tariffs, Zeeman's Health and Airs,
- 1:50Speaker 3: the German medical technology company has also raised the alarms
- 1:54Speaker 3: around that.
- 1:54Speaker 1: Yeah, so it expects tariff impact to double to four
- 1:57Speaker 1: hundred million euros in its fiscal year twenty two. So
- 2:01Speaker 1: the medical tech sector that Semens Health Andaiers is part
- 2:03Speaker 1: of is particularly exposed to those tariffs, to those trade tensions.
- 2:07Speaker 1: We had Phillips yesterday which has appeared to Semens Health
- 2:10Speaker 1: anders projecting as much as two hundred million euros of
- 2:14Speaker 1: tariff impact this year as well. We're still are waiting
- 2:17Speaker 1: for more details. So the US launched a probe in
- 2:20Speaker 1: September into imports of medical devices, and that might lead
- 2:23Speaker 1: to fresh tariffs, but it sounded kind of unclear at
- 2:27Speaker 1: this point whether that would stack on top of the
- 2:29Speaker 1: fifteen percent rate that was agreed between the US and
- 2:32Speaker 1: the EU. So in the meantime that's creating a lot
- 2:35Speaker 1: of uncertainty for those companies like Semens Health Andaers and
- 2:38Speaker 1: the shares did take quite a beating this morning after
- 2:42Speaker 1: projecting that tariff impact.
- 2:44Speaker 3: And chlarin ovnrdisks cut its forecasts for a fourth time
- 2:47Speaker 3: this year. They've cited lower sales and its blockbuster weight
- 2:51Speaker 3: loss drugs we Go vian A, zem Pic. The shares
- 2:54Speaker 3: have been all over the place this morning.
- 2:55Speaker 2: Just tell us more.
- 2:57Speaker 1: Yeah, the chairs found, then Pedo's last and it down again.
- 3:00Speaker 1: It seems that investors are trying to digest what is
- 3:02Speaker 1: good and what is bad from those updates this morning.
- 3:04Speaker 1: So on the negative side, we have got those falling
- 3:07Speaker 1: sales of wigo Vi and ozempic and continued competition from
- 3:10Speaker 1: Eli Lilly that has led Nova to cut its guidance
- 3:13Speaker 1: for the fourth time. As you mentioned, those profit warnings
- 3:16Speaker 1: throughout the year and also a shakeups in management have
- 3:19Speaker 1: dragged down the shares quite a lot throughout the entire year.
- 3:22Speaker 1: But then on the positive side, it looks like the
- 3:24Speaker 1: new CEO is keen to turn things around and has
- 3:26Speaker 1: been making progress there. We recently had news of quite
- 3:30Speaker 1: big layoffs as part of efforts to cut costs, and
- 3:33Speaker 1: crucially now we've also got this ten billion dollar offer
- 3:35Speaker 1: for Mid Sarah, the obesity startup, and Nova trying to
- 3:39Speaker 1: outbid Visor, and the CEO said this morning that he
- 3:42Speaker 1: was quite bullish about its chances of winning Mid Sarah,
- 3:45Speaker 1: saying on a press call that he was confidenced they
- 3:47Speaker 1: were confident there were no antitrust issues there, so that
- 3:51Speaker 1: could have contributed to those shares maybe getting that boost.
- 3:55Speaker 2: The stock mover's report from Bloomberg Radio. Check back with
- 4:00Speaker 2: us throughout the day for the latest roundup of companies
- 4:02Speaker 2: making news on Wall Street and for the latest market
- 4:05Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:10Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:13Speaker 2: the Bloomberg Business app,